Givastomig ESMO 2026 Poster and Supporting Analyses
Oct 25, 2026 from 7:00 AM to 7:45 AM EDT
Title: Expanded Safety and Efficacy of Givastomig, a Claudin 18.2/4-1BB Bispecific Antibody, in Combination with Nivolumab and mFOLFOX in 1L Metastatic Gastroesophageal Carcinoma (mGEC)
Presentation Number: 2945P
Presenter: Samuel J. Klempner, MD, Associate Professor of Medicine at Massachusetts General Hospital
Date: Sunday, October 25, 2026
Time: 12:00 p.m. - 12:45 p.m. CET
Location: Poster Area, Hall 5